Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

Delayed Quote. Delayed  - 09/27 03:52:30 pm
2.6 CHF   +0.78%
09/20 ADDEX THERAPEUT : Collaborators Published New Data Supporting the Ro..
07/27 ADDEX THERAPEUT : ADX71441 Demonstrates Positive Results in Highly T..
07/20 ADDEX THERAPEUT : LifeSci Capital Issues Equity Research Report on A..
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
09/21/2016 09/22/2016 09/23/2016 09/26/2016 09/27/2016 Date
2.65(c) 2.62(c) 2.58(c) 2.58(c) 2.6(c) Last
2 313 10 687 5 070 17 524 21 Volume
-1.85% -1.13% -1.53% 0.00% +0.78% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company was founded by Vincent Mutel, Timothy Dyer and Mark Epping-Jordan in May 2002 and is headquartered in Geneva, Switzerland. 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
09/20 ADDEX THERAPEUTICS : Collaborators Published New Data Supporting the Role of Neg..
07/27 ADDEX THERAPEUTICS : ADX71441 Demonstrates Positive Results in Highly Translatio..
07/20 ADDEX THERAPEUTICS : LifeSci Capital Issues Equity Research Report on Addex Ther..
07/19 ADDEX THERAPEUTICS LTD : LifeSci Capital Initiates Coverage of Addex Therapeutic..
06/24 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
06/24 ADDEX THERAPEUTICS : Shareholders Approved all Board Proposals at 2016 Annual Ge..
06/13 ADDEX THERAPEUTICS : mGluR4 and mGluR7 Programs Demonstrate Potential in Preclin..
06/09 ADDEX THERAPEUTICS : ADX71441 Demonstrates Positive Results in Non-Human Primate..
06/08 ADDEX THERAPEUTICS : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics
06/02 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
More news
Sector news : Biotechnology & Medical Research - NEC
09/27DJAMGEN : Myeloma Treatment Study Fails to Meet Primary Endpoint
09/26DJPfizer Throws Out Plan to Split Into Two Companies
09/26DJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Technical analysis trends ADDEX THERAPEUTIC...
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Managers
NameTitle
Timothy Dyer Chief Executive Officer
Vincent M. Lawton Chairman
Sonia Maria Poli Chief Scientific Officer
Raymond George Hill Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD-9.47%36
INCYTE CORPORATION-17.87%16 687
CELLTRION, INC.--.--%11 639
LONZA GROUP AG11.83%9 948
QUINTILES TRANSNATIONA..16.08%9 402
SEATTLE GENETICS, INC.26.05%7 828
More Results